Pharmac is considering declining 97 inactive medicine funding applications. Previously inactive applications have remained on PHARMAC’s books, despite being unlikely to be approved for funding
Māori and Pacific children face more barriers to seeing a GP than other children and those who do are twice as likely to be hospitalised, according to a new report led by a Te Herenga Waka—Victoria University of Wellington researcher
Source
Media release from Te Herenga Waka—Victoria University of Wellington
Scientists at Te Herenga Waka—Victoria University of Wellington have used real-world samples to confirm the 98.7 percent accuracy of a saliva test for COVID-19. This is the first, and currently the only, COVID-19 saliva test to be diagnostically validated in Aotearoa New Zealand
Source
Te Herenga Waka - Victoria University of Wellington
Debbie Wallace recently stepped down from her role as Manager of the EVOLVE Intern Training Programme with the Pharmaceutical Society of New Zealand to take up a new role as Quality and Risk Team Lead Pharmacy at Wellington Hospital
Source
Media release from the Pharmaceutical Society of New Zealand
PHARMAC has reached a provisional agreement with medicine supplier Teva to fund a new brand of primidone which is most commonly used to treat and prevent seizures in people with epilepsy
Warringal Private Hospital’s Day Oncology team has helped uncover an innovative new solution for medication packaging, helping to reduce the use of plastic and polystyrene across the Ramsay Health Care network
It’s World Allergy Week this week (13-19 June), and the Asthma and Respiratory Foundation NZ (ARFNZ) is encouraging people to be aware of their winter allergy triggers
Source
Media release from Asthma and Respiratory Foundation
Aucklanders aged 65 and over will receive an invitation to book their COVID-19 vaccination within the next week as Group 3 continues to roll out across the Auckland metro region
Source
Media release from the Northern Region Health Coordination Centre
New Zealand based Douglas Pharmaceuticals Ltd is pleased to announce that a majority of patients with Treatment Resistant Depression experienced rapid relief of their symptoms when treated with R-107 (extended-release oral dose of ketamine) in a Phase 2 study
The Ministry of Health has confirmed there is sufficient supply of the Pfizer vaccine for district health boards to deliver more than half a million vaccinations as planned over the next five weeks
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes